Elsevier

The Lancet

Volume 345, Issue 8951, 18 March 1995, Pages 726-727
The Lancet

Letters to the Editor
Sensitivity of screening sigmoidoscopy for proximal colorectal tumours

https://doi.org/10.1016/S0140-6736(95)90899-4Get rights and content

References (3)

There are more references available in the full text version of this article.

Cited by (21)

  • Colorectal Cancer Screening

    2017, Surgical Clinics of North America
    Citation Excerpt :

    It has been stated that FSIG is 60% to 70% as sensitive for detecting CRC and advanced adenomas as colonoscopy.24 The sensitivity of this screening modality may vary with age, gender, and race because some studies have shown variability in the prevalence of proximal adenomas based on these factors.24,48 FSIG can be performed in the office and often with little or no need for sedation.24

  • Rationale for colonoscopy screening and estimated effectiveness in clinical practice

    2002, Gastrointestinal Endoscopy Clinics of North America
  • Which colon cancer screening test? A comparison of costs, effectiveness, and compliance

    2001, American Journal of Medicine
    Citation Excerpt :

    Screening affected mortality in two ways: prevention of cancer through removal of adenomatous polyps and detection of cancer in earlier stages (Table 1). The sensitivity, specificity, and complication rates of the screening tests were derived from observational studies (34–41,44–49,58). For flexible sigmoidoscopy, we assumed that a 70-cm sigmoidoscope could detect 55% of polyps and cancers (eg, flexible sigmoidoscopy “reached” 55% of all lesions); this was varied from 40% to 75% in sensitivity analyses (15,41–43).

  • Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology

    2000, American Journal of Gastroenterology
    Citation Excerpt :

    Thus, colonoscopy is currently the dominant strategy available for adenoma detection. Fourth, retrospective (36–42) and prospective (43) studies of colonoscopy findings in patients with colon cancer proximal to the splenic flexure have consistently found that at least two-thirds of these patients have no neoplasm distal to the splenic flexure. Currently nearly 40% of colorectal cancers in the United States arise proximal to the splenic flexure (44).

View all citing articles on Scopus
View full text